Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2026-01-16 @ 11:16 AM
Study NCT ID:
NCT05579366
Status:
RECRUITING
Last Update Posted:
2025-12-05
First Post:
2022-10-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Sponsor:
Genmab
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GCT1184-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None